Tessera Therapeutics Stock

Private Company · Price from Hiive

$2.50 0.00 (0.00%)

As of Sep 4, 2026

Tessera Therapeutics Valuation

Last Confirmed

$1.7B

Current Implied

n/a

Growth Rate

518.5%

Rank

Funding Rounds

Total Raised

$545M

Date	Round	RaisedAmount Raised	Valuation	Change
Apr 19, 2022	Series C	$300M	$1.7B	+123.49%
Jan 12, 2021	Series B	$230M	$760.65M	+1,051.10%
Jul 7, 2020	Series A	$14.7M	$66.08M	n/a